<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">helmholtzeyeinstitute</journal-id><journal-title-group><journal-title xml:lang="ru">Российский офтальмологический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Ophthalmological Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-0076</issn><issn pub-type="epub">2587-5760</issn><publisher><publisher-name>Real time Publishers</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21516/2072-0076-2021-14-1-35-41</article-id><article-id custom-type="elpub" pub-id-type="custom">helmholtzeyeinstitute-579</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL STUDIES</subject></subj-group></article-categories><title-group><article-title>Электрофизиологические маркеры доклинической диагностики глаукомной оптической нейропатии</article-title><trans-title-group xml:lang="en"><trans-title>Electrophysiological markers of preclinical diagnosis of glaucomatous optic neuropathy</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1813-4408</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кириллова</surname><given-names>М. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Kirillova</surname><given-names>M. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мария Олеговна Кириллова — аспирант отдела глаукомы.</p><p>Ул. Садовая-Черногрязская, д. 14/19, Москва, 105062</p></bio><bio xml:lang="en"><p>Maria O. Kirillova — PhD Student, Glaucoma Department.</p><p>14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062</p></bio><email xlink:type="simple">mkirillova.92@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0161-5010</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зуева</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Zueva</surname><given-names>M. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Марина Владимировна Зуева — доктор биологических наук, профессор, начальник отдела клинической физиологии зрения им. С.В. Кравкова.</p><p>Ул. Садовая-Черногрязская, д. 14/19, Москва, 105062</p></bio><bio xml:lang="en"><p>Marina V. Zueva — Dr. of Biol. Sci., professor, head of the department of clinical physiology of vision named after S.V. Kravkov.</p><p>14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062</p></bio><email xlink:type="simple">visionlab@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0148-8517</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Цапенко</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Tsapenko</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ирина Владимировна Цапенко — кандидат биологических наук, старший научный сотрудник отдела клинической физиологии зрения им. С.В. Кравкова.</p><p>Ул. Садовая-Черногрязская, д. 14/19, Москва, 105062</p></bio><bio xml:lang="en"><p>Irina V. Tsapenko — Cand. of Biol. Sci., senior researcher, department of clinical physiology of vision named after S.V. Kravkov.</p><p>14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062</p></bio><email xlink:type="simple">sunvision@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8381-2124</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Журавлева</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Zhuravleva</surname><given-names>A. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Анастасия Николаевна Журавлева — кандидат медицинских наук, научный сотрудник отдела глаукомы.</p><p>Ул. Садовая-Черногрязская, д. 14/19, Москва, 105062</p></bio><bio xml:lang="en"><p>Anastasiya N. Zhuravleva — Cand. of Med. Sci., researcher, glaucoma department.</p><p>14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062</p></bio><email xlink:type="simple">visionlab@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ НМИЦ глазных болезней им. Гельмгольца» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Helmholtz National Medical Research Center of Eye Diseases</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>19</day><month>03</month><year>2021</year></pub-date><volume>14</volume><issue>1</issue><fpage>35</fpage><lpage>41</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Кириллова М.О., Зуева М.В., Цапенко И.В., Журавлева А.Н., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Кириллова М.О., Зуева М.В., Цапенко И.В., Журавлева А.Н.</copyright-holder><copyright-holder xml:lang="en">Kirillova M.O., Zueva M.V., Tsapenko I.V., Zhuravleva A.N.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://roj.igb.ru/jour/article/view/579">https://roj.igb.ru/jour/article/view/579</self-uri><abstract><p>Цель — оценить специфику изменений электрофизиологических показателей, отражающих различные аспекты функции ганглиозных клеток (ГК) и их аксонов, в ранней диагностике глаукомной оптической нейропатии (ГОН).</p><sec><title>Материал и методы</title><p>Материал и методы. В двух клинических группах: (I) с подозрением на глаукому — 35 пациентов (60 глаз) в возрасте 49–70 лет и (II) с начальной первичной открытоугольной глаукомой (ПОУГ) — 16 пациентов (30 глаз) в возрасте 43–68 лет, а также в группе сравнения 38 относительно здоровых лиц (45 глаз) в возрасте 42–70 лет регистрировали паттерн-реверсивные зрительные вызванные потенциалы (ПЗВП), транзиентную и стационарную паттерн-ЭРГ (ПЭРГ) по стандартам ISCEV и фотопический негативный ответ (ФНО).</p></sec><sec><title>Результаты</title><p>Результаты. Амплитуды Р100 в обеих клинических группах достоверно отличались от нормы в ПЗВП на мелкие и крупные паттерны. Удлинение пиковой латентности (Т) Р100 по сравнению с нормой статистически значимо для стимула 1° во II группе. В обеих группах обнаружена повышенная вариабельность временных параметров ПЭРГ и ПЗВП для мелких паттернов. В I и II группах выявлено снижение амплитуды Р50 и N95 транзиентной ПЭРГ на все стимулы, наиболее значительное для паттерна 0,3°. В I группе Т N95 достоверно удлинена в ПЭРГ на крупный стимул. Достоверная редукция стационарной ПЭРГ обнаружена в группах и подозрения на глаукому, и начальной ПОУГ. Наиболее резкие изменения отмечены для мелких паттернов 0,8 и 0,3°. Удлинение Т по сравнению с нормой наиболее выражено для ПЭРГ на 0,3°, однако из-за высокой вариабельности показателя внутри группы оно не имело статистической значимости. Амплитуда ФНО достоверно отличалась от нормы в ЭРГ на вспышку 3,0 кд·с/м2.</p></sec><sec><title>Заключение</title><p>Заключение. У пациентов с подозрением на глаукому снижение амплитуды Р100 ЗВП и одновременное удлинение его Т может являться одним из критериев пластической стадии на уровне латерального коленчатого тела. Маркерами функциональных изменений ГК сетчатки являются снижение амплитуды ФНО на яркую вспышку и волн Р50 и N95 транзиентной ПЭРГ на паттерн 0,3°. Результаты указывают на большую чувствительность парвоцеллюлярной системы к ранним событиям в развитии ГОН.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Purpose</title><p>Purpose: to evaluate the changes in electrophysiological indicators reflecting various aspects of the function of retinal ganglion cells (RGC) and their axons in the early diagnosis of glaucomatous optic neuropathy (GON).</p></sec><sec><title>Material and methods</title><p>Material and methods. Two clinical groups, (1) 35 patients (60 eyes) aged 49 to 70 with suspected glaucoma and (2) 16 patients (30 eyes) aged 43–68 with initial primary open-angle glaucoma (POAG), and a comparison group of 38 relatively healthy subjects (45 eyes) aged 42–70 were tested for pattern-reversed visual evoked potentials (PVEP), transient and stationary pattern-ERGs (PERG) according to ISCEV, and photopic negative response (PhNR).</p></sec><sec><title>Results</title><p>Results. The P100 amplitudes in both clinical groups differed significantly from the norm in PVEP on small and large patterns. The elongation of peak latency (T) of P100 compared with norm was significant for the stimulus 1° in group 2. In both groups of patients, increased variability of the temporal parameters of PERG and PVEP for small patterns was found. In groups 1 and 2, a decrease in the amplitude of P50 and N95 peaks of transient PERG for all stimuli was revealed, which was the most significant for the 0.3° pattern. In group 1, the N95 peak was significantly delayed in PERG for large patterns. A statistically significant reduction in the steady-state PERG's amplitude was found in the groups of suspected glaucoma and initial POAG. The sharpest changes were found for small (0.8° and 0.3°) patterns. The elongation of T compared to the norm was most pronounced for PERG at 0.3°, but due to the high variability of temporary indicators within the group, it had no statistical significance. The amplitude of PhNR was significantly different from the norm in the ERG for a flash of 3.0 cd·sec/m2.</p></sec><sec><title>Conclusion</title><p>Conclusion. In patients with suspected glaucoma, a decrease in the P100 VEP amplitude with the simultaneous elongation of T may be considered as a criteria for the plastic stage at the level of lateral geniculate nucleus. Markers of functional changes in RGCs are the decrease in the amplitude of PhNR in response to bright flash, and P50 and N95 of PERG for pattern size 0.3°. The results indicate a greater vulnerability of the parvocellular system to early events in the development of GON.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>доклиническая диагностика</kwd><kwd>подозрение на глаукому</kwd><kwd>начальная первичная открытоугольная глаукома</kwd><kwd>ганглиозные клетки сетчатки</kwd><kwd>паттерн-ЭРГ</kwd><kwd>фотопический негативный ответ</kwd><kwd>зрительные вызванные потенциалы</kwd></kwd-group><kwd-group xml:lang="en"><kwd>preclinical diagnosis</kwd><kwd>suspected glaucoma</kwd><kwd>initial primary open-angle glaucoma</kwd><kwd>retinal ganglion cells</kwd><kwd>pattern-ERG</kwd><kwd>photopic negative response</kwd><kwd>visual evoked potentials</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Quigley H.A., Broman A.T. The number of people with glaucoma worldwide in 2010 and 2020. Br. J. Ophthalmol. 2006; 90: 262–7. http://dx.doi.org/10.1136/bjo.2005.081224</mixed-citation><mixed-citation xml:lang="en">Quigley H.A., Broman A.T. The number of people with glaucoma worldwide in 2010 and 2020. Br. J. Ophthalmol. 2006; 90: 262–7. http://dx.doi.org/10.1136/bjo.2005.081224</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Leske M.C., Wu S.Y., Hennis A., Honkanen R.A., Nemesure B. Risk factors for incident open-angle glaucoma: the Barbados Eye Studies. Ophthalmology. 2008; 115 (1): 85–93. https://doi.org/10.1016/j.ophtha.2007.03.017</mixed-citation><mixed-citation xml:lang="en">Leske M.C., Wu S.Y., Hennis A., Honkanen R.A., Nemesure B. Risk factors for incident open-angle glaucoma: the Barbados Eye Studies. Ophthalmology. 2008; 115 (1): 85–93. https://doi.org/10.1016/j.ophtha.2007.03.017</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Jiang X., Varma R., Wu S., et al. Baseline risk factors that predict the development of open-angle glaucoma in a population: the Los Angeles Latino Eye Study. Ophthalmology. 2012; 119 (11): 2245–53. https://doi.org/10.1016/j.ophtha.2012.05.030</mixed-citation><mixed-citation xml:lang="en">Jiang X., Varma R., Wu S., et al. Baseline risk factors that predict the development of open-angle glaucoma in a population: the Los Angeles Latino Eye Study. Ophthalmology. 2012; 119 (11): 2245–53. https://doi.org/10.1016/j.ophtha.2012.05.030</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Журавлева А.Н., Киселева О.А., Кириллова М.О. Персонализированная медицина в решении проблемы глаукомы. Российский офтальмологический журнал. 2019; 12 (3): 95–100. https://doi.org/10.21516/2072-0076-2019-12-3-95-100]</mixed-citation><mixed-citation xml:lang="en">Zhuravleva A.N., Kiseleva O.A., Kirillova M.O. Personalized medicine in solving the problem of glaucoma. Russian ophthalmological journal. 2019; 12 (3): 95–100 (in Russian). https://doi.org/10.21516/2072-0076-2019-12-3-95-100</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Banitt M.R., Ventura L.M., Feuer W.J., et al. Progressive loss of retinal ganglion cell function precedes structural loss by several years in glaucoma suspects. Invest. Ophthalmol. Vis. Sci. 2013; 54 (3): 2346–52. doi: 10.1167/iovs.12-11026</mixed-citation><mixed-citation xml:lang="en">Banitt M.R., Ventura L.M., Feuer W.J., et al. Progressive loss of retinal ganglion cell function precedes structural loss by several years in glaucoma suspects. Invest. Ophthalmol. Vis. Sci. 2013; 54 (3): 2346–52. doi: 10.1167/iovs.12-11026</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Park S.B., Sung K.R., Kang S.Y., Kim K.R., Kook M.S. Comparison of glaucoma diagnostic capabilities of cirrus HD and stratus optical coherence tomography. Arch. Ophthalmol. 127: 16031609. https://doi.org/10.1001/archophthalmol.2009.296</mixed-citation><mixed-citation xml:lang="en">Park S.B., Sung K.R., Kang S.Y., Kim K.R., Kook M.S. Comparison of glaucoma diagnostic capabilities of cirrus HD and stratus optical coherence tomography. Arch. Ophthalmol. 127: 16031609. https://doi.org/10.1001/archophthalmol.2009.296</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Medeiros F.A., Zangwill L.M., Bowd C., et al. Evaluation of retinal nerve fiber layer, optic nerve head, and macular thickness measurements for glaucoma detection using optical coherence tomography. Am. J. Ophthalmol. 2005; 139: 44–55. https://doi.org/10.1016/j.ajo.2004.08.069</mixed-citation><mixed-citation xml:lang="en">Medeiros F.A., Zangwill L.M., Bowd C., et al. Evaluation of retinal nerve fiber layer, optic nerve head, and macular thickness measurements for glaucoma detection using optical coherence tomography. Am. J. Ophthalmol. 2005; 139: 44–55. https://doi.org/10.1016/j.ajo.2004.08.069</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Leite M.T., Rao H.L., Zangwill L.M., Weinreb R.N., Medeiros F.A. Comparison of the diagnostic accuracies of the Spectralis, Cirrus, and RTVue optical coherence tomography devices in glaucoma. Ophthalmology. 2011; 118: 1331339. doi.org/10.1016/j.ophtha.2010.11.029</mixed-citation><mixed-citation xml:lang="en">Leite M.T., Rao H.L., Zangwill L.M., Weinreb R.N., Medeiros F.A. Comparison of the diagnostic accuracies of the Spectralis, Cirrus, and RTVue optical coherence tomography devices in glaucoma. Ophthalmology. 2011; 118: 1331339. doi.org/10.1016/j.ophtha.2010.11.029</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Нероев В.В., Зуева М.В., Журавлева А.Н., Цапенко И.В. Структурно-функциональные нарушения при глаукоме: перспективы доклинической диагностики. Часть 2. Электрофизиологические маркеры ранних нейропластических событий. Офтальмология. 2021; 18 (1): 533–41. https://doi.org/10.18008/1816-5095-2020-3S-533-541</mixed-citation><mixed-citation xml:lang="en">Neroev V.V., Zueva M.V., Zhuravleva A.N., Tsapenko I.V. Structural and functional disorders in glaucoma: prospects for preclinical diagnosis. Part 2. Electrophysiological markers of early neuroplastic events. Ophthalmology in Russia. 2021; 18 (1): 533–41 (in Russian). https://doi.org/10.18008/1816-5095-2020-3S-533-541</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Kaur C., Foulds W.S., Ling E.A. Blood retinal barrier in hypoxic ischaemic conditions: basic concepts, clinical features and management. Progr. Retinal Eye Res. 2008; 27 (6): 622–47 https://doi.org/10.1016/j.preteyeres.2008.09.003</mixed-citation><mixed-citation xml:lang="en">Kaur C., Foulds W.S., Ling E.A. Blood retinal barrier in hypoxic ischaemic conditions: basic concepts, clinical features and management. Progr. Retinal Eye Res. 2008; 27 (6): 622–47 https://doi.org/10.1016/j.preteyeres.2008.09.003</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Tan O., Li G., Lu A.T., et al. Mapping of macular substructures with optical coherence tomography for glaucoma diagnosis. Ophthalmology. 2008; 115: 949–56. https://doi.org/10.1016/j.ophtha.2007.08.011</mixed-citation><mixed-citation xml:lang="en">Tan O., Li G., Lu A.T., et al. Mapping of macular substructures with optical coherence tomography for glaucoma diagnosis. Ophthalmology. 2008; 115: 949–56. https://doi.org/10.1016/j.ophtha.2007.08.011</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Chien J.L., Ghassibi M.P., Patthanathamrongkasem T., et al. Glaucoma diagnostic capability of global and regional measurements of isolated ganglion cell layer and inner plexiform layer. J. Glaucoma. 2017; 26 (3): 208–15. https://doi.org/10.1097/ijg.0000000000000572</mixed-citation><mixed-citation xml:lang="en">Chien J.L., Ghassibi M.P., Patthanathamrongkasem T., et al. Glaucoma diagnostic capability of global and regional measurements of isolated ganglion cell layer and inner plexiform layer. J. Glaucoma. 2017; 26 (3): 208–15. https://doi.org/10.1097/ijg.0000000000000572</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Kim H.J., Lee S.Y., Park K.H., Kim D.M., Jeoung J.W. Glaucoma diagnostic ability of layer-by-layer segmented ganglion cell complex by Spectral-Domain Optical Coherence Tomography. Invest. Ophthalmol. Vis Sci. 2016 Sep 1; 57 (11): 4799–805. https://doi.org/10.1167/iovs.16-19214</mixed-citation><mixed-citation xml:lang="en">Kim H.J., Lee S.Y., Park K.H., Kim D.M., Jeoung J.W. Glaucoma diagnostic ability of layer-by-layer segmented ganglion cell complex by Spectral-Domain Optical Coherence Tomography. Invest. Ophthalmol. Vis Sci. 2016 Sep 1; 57 (11): 4799–805. https://doi.org/10.1167/iovs.16-19214</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Kerrigan-Baumrind L.A., Quigley H.A., Pease M.E., Kerrigan D.F., Mitchell R.S. Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons. Invest. Ophthalmol.Vis. Sci. 2000; 41: 741–8.</mixed-citation><mixed-citation xml:lang="en">Kerrigan-Baumrind L.A., Quigley H.A., Pease M.E., Kerrigan D.F., Mitchell R.S. Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons. Invest. Ophthalmol.Vis. Sci. 2000; 41: 741–8.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Quigley H.A., Nickells R.W., Kerrigan L.A., et al. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest. Ophthalmol. Vis. Sci. 1995; 36 (5): 774–86. https://doi.org 10.1007/bf00194473</mixed-citation><mixed-citation xml:lang="en">Quigley H.A., Nickells R.W., Kerrigan L.A., et al. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest. Ophthalmol. Vis. Sci. 1995; 36 (5): 774–86. https://doi.org 10.1007/bf00194473</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Porciatti V., Ventura L.M. Retinal ganglion cell functional plasticity and optic neuropathy: a comprehensive model. J. Neuroophthalmol. 2012; 32 (4): 354–38. https://doi.org/10.1097/WNO.0b013e3182745600</mixed-citation><mixed-citation xml:lang="en">Porciatti V., Ventura L.M. Retinal ganglion cell functional plasticity and optic neuropathy: a comprehensive model. J. Neuroophthalmol. 2012; 32 (4): 354–38. https://doi.org/10.1097/WNO.0b013e3182745600</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Зуева М.В. Динамика гибели ганглиозных клеток сетчатки при глаукоме и ее функциональные маркеры. Национальный журнал глаукома. 2016; 15 (1): 70–85.</mixed-citation><mixed-citation xml:lang="en">Zueva M.V. Dynamics of retinal ganglion cell death in glaucoma and its functional markers. Russian Journal of Glaucoma. 2016; 15 (1): 70–85 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Morgan J.E. Retina ganglion cell degeneration in glaucoma: an opportunity missed? A review. Clin. Exp. Ophthalmol. 2012; 40: 364–68.</mixed-citation><mixed-citation xml:lang="en">Morgan J.E. Retina ganglion cell degeneration in glaucoma: an opportunity missed? A review. Clin. Exp. Ophthalmol. 2012; 40: 364–68.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Журавлева А.Н., Зуева М.В. Гипотензивная терапия глаукомы и нейропротекция. Российский офтальмологический журнал. 2020; 13 (2): 78–82. https://doi.org/10.21616/2072-0076-2020-13-2-78-82</mixed-citation><mixed-citation xml:lang="en">Zhuravleva A.N., Zueva M.V. Hypotensive glaucoma therapy and neuroprotection. Russian ophthalmological journal. 2020; 13 (2): 78–82 (in Russian). https://doi.org/10.21616/2072-0076-2020-13-2-78-82</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Bach M., Brigell M.G., Hawlina M., et al. ISCEV standard for clinical pattern electroretinography (PERG). Doc. Ophthalmol. 2013; 126: 1–7. doi.org/10.1007/s10633-012-9353-y</mixed-citation><mixed-citation xml:lang="en">Bach M., Brigell M.G., Hawlina M., et al. ISCEV standard for clinical pattern electroretinography (PERG). Doc. Ophthalmol. 2013; 126: 1–7. doi.org/10.1007/s10633-012-9353-y</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Odom J.V., Bach M., Brigell M., et al. ISCEV standard for clinical visual evoked potentials: (2016 update). Doc Ophthalmol. 2016; 133: 1–9. https://doi.org/10.1007/s10633-016-9553-y</mixed-citation><mixed-citation xml:lang="en">Odom J.V., Bach M., Brigell M., et al. ISCEV standard for clinical visual evoked potentials: (2016 update). Doc Ophthalmol. 2016; 133: 1–9. https://doi.org/10.1007/s10633-016-9553-y</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Frishman L., Sustar M., Kremers J., et al. ISCEV extended protocol for the photopic negative response (PhNR) of the full-field electroretinogram. Doc. Ophthalmol. 2018; 36 (3): 207–11. doi: 10.1007/s10633-018-9638-x</mixed-citation><mixed-citation xml:lang="en">Frishman L., Sustar M., Kremers J., et al. ISCEV extended protocol for the photopic negative response (PhNR) of the full-field electroretinogram. Doc. Ophthalmol. 2018; 36 (3): 207–11. doi: 10.1007/s10633-018-9638-x</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Котелин В.И., Кириллова М.О., Зуева М.В. и др. Фотопический негативный ответ для оценки функции внутренней сетчатки — требования к регистрации и сравнение в глазах с естественной шириной зрачка и в условиях медикаментозного мидриаза. Офтальмология. 2020;17 (3): 398–406. https://doi.org/10.18008/1816-5095-2020-3-398-406</mixed-citation><mixed-citation xml:lang="en">Kotelin V.I., Kirillova M.O., Zueva M.V., et al. Photopic negative response for testing the function of inner retina – registration requirements and comparison in the eyes with natural pupil width and in conditions of drug mydriasis. Ophthalmology in Russia. 2020; 17 (3): 398–406 (in Russian). https://doi.org/10.18008/1816-5095-2020-3-398-406</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Çavdar E., Ozkaya A., Alper B. Flash electroretinography and pattern visual evoked potential changes in ocular hypertension patients. J. Ophthalmol. 2013; 2013: 908017. https://doi.org/10.1155/2013/908017</mixed-citation><mixed-citation xml:lang="en">Çavdar E., Ozkaya A., Alper B. Flash electroretinography and pattern visual evoked potential changes in ocular hypertension patients. J. Ophthalmol. 2013; 2013: 908017. https://doi.org/10.1155/2013/908017</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Parisi V., Manni G., Centofanti M., et al. Correlation between optical coherence tomography, pattern electroretinogram, and visual evoked potentials in openangle glaucoma patients. Ophthalmology. 2001; 108: 905–12. https://doi.org/10.1016/s0161-6420(00)00644-8</mixed-citation><mixed-citation xml:lang="en">Parisi V., Manni G., Centofanti M., et al. Correlation between optical coherence tomography, pattern electroretinogram, and visual evoked potentials in openangle glaucoma patients. Ophthalmology. 2001; 108: 905–12. https://doi.org/10.1016/s0161-6420(00)00644-8</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Rodarte C., Hood D. C., Yang E. B., et al. The effects of glaucoma on the latency of the multifocal visual evoked potential. Brit. J. Ophthalmol. 2006; 90 (9): 1132–6. http://dx.doi.org/10.1136/bjo.2006.097592</mixed-citation><mixed-citation xml:lang="en">Rodarte C., Hood D. C., Yang E. B., et al. The effects of glaucoma on the latency of the multifocal visual evoked potential. Brit. J. Ophthalmol. 2006; 90 (9): 1132–6. http://dx.doi.org/10.1136/bjo.2006.097592</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Glovinsky Y., Quigley H.A., Dunkelberger G.R. Retinal ganglion cell loss is size dependent in experimental glaucoma. Invest. Ophthalmol. Vis. Sci. 1991; 32 (3): 484–91. PMID: 2001923</mixed-citation><mixed-citation xml:lang="en">Glovinsky Y., Quigley H.A., Dunkelberger G.R. Retinal ganglion cell loss is size dependent in experimental glaucoma. Invest. Ophthalmol. Vis. Sci. 1991; 32 (3): 484–91. PMID: 2001923</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Quigley H.A. Selectivity in glaucoma injury. Arch Ophthalmol. 1998 Mar; 116 (3): 396–8. PMID: 9514503</mixed-citation><mixed-citation xml:lang="en">Quigley H.A. Selectivity in glaucoma injury. Arch Ophthalmol. 1998 Mar; 116 (3): 396–8. PMID: 9514503</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Sample P.A., Bosworth C.F., Weinreb R.N. The loss of visual function in glaucoma. Semin. Ophthalmol. 2000; 15 (4): 182–93. https://doi.org/10.3109/08820530009037870</mixed-citation><mixed-citation xml:lang="en">Sample P.A., Bosworth C.F., Weinreb R.N. The loss of visual function in glaucoma. Semin. Ophthalmol. 2000; 15 (4): 182–93. https://doi.org/10.3109/08820530009037870</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Dacey D.M., Lee B.B. The ‘blue-on’ opponent pathway in primate retina originates from a distinct bistratified ganglion cell type. Nature. 1994; 367: 731–5. doi: 10.1038/367731a0</mixed-citation><mixed-citation xml:lang="en">Dacey D.M., Lee B.B. The ‘blue-on’ opponent pathway in primate retina originates from a distinct bistratified ganglion cell type. Nature. 1994; 367: 731–5. doi: 10.1038/367731a0</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Bray L.C., Mitchell K.W., Howe J.W. Prognostic significance of the pattern visual evoked potential in ocular hypertension. Br. J. Ophthalmol. 1991; 75 (2): 79–83. https://doi.org/10.1136/bjo.75.2.79</mixed-citation><mixed-citation xml:lang="en">Bray L.C., Mitchell K.W., Howe J.W. Prognostic significance of the pattern visual evoked potential in ocular hypertension. Br. J. Ophthalmol. 1991; 75 (2): 79–83. https://doi.org/10.1136/bjo.75.2.79</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Lubiński W., Gosławski W., Penkala K., Szych Z., Karczewicz D. Retinal ganglion cells function measured by the PERG test in patients with ocular hypertension. Klinika Oczna. 2011; 113 (4–6): 122–6. PMID: 21913439</mixed-citation><mixed-citation xml:lang="en">Lubiński W., Gosławski W., Penkala K., Szych Z., Karczewicz D. Retinal ganglion cells function measured by the PERG test in patients with ocular hypertension. Klinika Oczna. 2011; 113 (4–6): 122–6. PMID: 21913439</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Demir S. T., Oba M.E., Erdoğan E.T., et al. Comparison of pattern electroretinography and optical coherence tomography parameters in patients with primary open-angle glaucoma and ocular hypertension. Turk. J. Ophthalmol. 2015; 45 (6): 229–34. http://dx.doi.org/10.4274/tjo.39260</mixed-citation><mixed-citation xml:lang="en">Demir S. T., Oba M.E., Erdoğan E.T., et al. Comparison of pattern electroretinography and optical coherence tomography parameters in patients with primary open-angle glaucoma and ocular hypertension. Turk. J. Ophthalmol. 2015; 45 (6): 229–34. http://dx.doi.org/10.4274/tjo.39260</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Зуева М.В., Арапиев М.У., Цапенко И.В. и др. Морфофункциональные особенности изменения ганглиозных клеток сетчатки при физиологическом старении и в ранней стадии глаукомы. Вестник офтальмологии. 2016; 1: 36–42. https://doi.org/10.17116/oftalma2016132136-42</mixed-citation><mixed-citation xml:lang="en">Zueva M.V., Arapiev M.U., Tsapenko I.V., et al. Morphological and functional features of changes in retinal ganglion cells during physiological aging and in the early stage of glaucoma. Vestnik oftal'mologii. 2016; 1: 36–42 (in Russian). https://doi.org/10.17116/oftalma2016132136-42</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Kirkiewicz M., Lubiński W., Penkala K. Photopic negative response of full-field electroretinography in patients with different stages of glaucomatous optic neuropathy. Doc. Ophthalmol. 2016; 132: 57–65. https://doi.org/10.1007/s10633-016-9528-z</mixed-citation><mixed-citation xml:lang="en">Kirkiewicz M., Lubiński W., Penkala K. Photopic negative response of full-field electroretinography in patients with different stages of glaucomatous optic neuropathy. Doc. Ophthalmol. 2016; 132: 57–65. https://doi.org/10.1007/s10633-016-9528-z</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Preiser D., Lagrèze W.A., Bach M., Poloschek C.M. Photopic negative response versus pattern electroretinogram in early glaucoma. Invest. Ophthalmol. Vis. Sci. 2013; 54 (2): 1182–91. https://doi.org/10.1167/iovs.12-11201</mixed-citation><mixed-citation xml:lang="en">Preiser D., Lagrèze W.A., Bach M., Poloschek C.M. Photopic negative response versus pattern electroretinogram in early glaucoma. Invest. Ophthalmol. Vis. Sci. 2013; 54 (2): 1182–91. https://doi.org/10.1167/iovs.12-11201</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Cvenkel B., Sustar M., Perovšek D. Ganglion cell loss in early glaucoma, as assessed by photopic negative response, pattern electroretinogram, and spectraldomain optical coherence tomography. Doc. Ophthalmol. 2017; 135: 17–28. https://doi.org/10.1007/s10633-017-9595-9</mixed-citation><mixed-citation xml:lang="en">Cvenkel B., Sustar M., Perovšek D. Ganglion cell loss in early glaucoma, as assessed by photopic negative response, pattern electroretinogram, and spectraldomain optical coherence tomography. Doc. Ophthalmol. 2017; 135: 17–28. https://doi.org/10.1007/s10633-017-9595-9</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">ElGohary A.A., Elshazly L.H. Photopic negative response in diagnosis of glaucoma: an experimental study in glaucomatous rabbit model. Int. J. Ophthalmol. 2015; 8 (3): 459–64. https://doi.org/10.3980/j.issn.2222-3959.2015.03.05</mixed-citation><mixed-citation xml:lang="en">ElGohary A.A., Elshazly L.H. Photopic negative response in diagnosis of glaucoma: an experimental study in glaucomatous rabbit model. Int. J. Ophthalmol. 2015; 8 (3): 459–64. https://doi.org/10.3980/j.issn.2222-3959.2015.03.05</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
